title: Carboxypeptidase U (TAFIa) activity is induced in vivo in ischemic stroke patients receiving thrombolytic therapy.
authors.forename: J L
authors.initials: JL
authors.lastname: Willemse
authors.forename: R
authors.initials: R
authors.lastname: Brouns
authors.forename: E
authors.initials: E
authors.lastname: Heylen
authors.forename: P P
authors.initials: PP
authors.lastname: De Deyn
authors.forename: D F
authors.initials: DF
authors.lastname: Hendriks
mesh_terms: D025901:Carboxypeptidase B2 / Q000235:genetics* / Q000502:physiology; D025461:Feedback, Physiological; D005786:Gene Expression Regulation / Q000187:drug effects; D006487:Hemostasis / Q000235:genetics; D006801:Humans; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000494:pharmacology; D020521:Stroke / Q000097:blood / Q000628:therapy; D015912:Thrombolytic Therapy
chemical_list: D025901:Carboxypeptidase B2; D010960:Plasminogen Activators